KD025 Is a Casein Kinase 2 Inhibitor That Protects Against Glucolipotoxicity in beta-Cells. Devkota R, Small JC, Carbone K, Glass MA, et al. Diabetes 2024;73:585-591.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Devkota R, Small JC, Carbone K, Glass MA, et al. KD025 Is a Casein Kinase 2 Inhibitor That Protects Against Glucolipotoxicity in beta-Cells. Diabetes 2024;73:585-591.
PMID: 38211571